Systemic radiotherapeutic ligand therapy such as Pluvicto had been reserved for those who had chemotherapy but now as of May 2025 its authorization no longer requires that step. What will be the next down? I assume it will be authorized for those with metastatic disease but are still hormone sensitive. Then oligometastatic ds, then 1 or two lymph node...next down to G8, 9 and 10. with a negative PSMA CT PET scan. Then unfavorable 7 (4+3). By then there may be a therapeutic vaccine. Ours is a slower ds.

BTW: Oregon State Health System has come up with $0.25 blood test for early pancreatic cancer diagnosis to be confirmed on a larger group. Another center has very promising initial results for a therapeutic vaccine against pancreatic cancer. Hold on boys the cavalry is on the way.